Schizophrenia Research
Volume 118, Issue 1 , Pages 183-188 , May 2010

Time course of antipsychotic treatment response in schizophrenia: Results from a naturalistic study in 280 patients

  • M. Jäger

      Affiliations

    • Department of Psychiatry, Ludwig-Maximilians-University, Nussbaumstr. 7, D-80336 Munich, Germany
    • Department of Psychiatry II, Ulm University, Ludwig-Heilmeyer-Str. 2, D-89312 Günzburg, Germany
    • Corresponding Author InformationCorresponding author. Department of Psychiatry II, Ulm University, BKH Günzburg Ludwig-Heilmeyer-Str. 2, D-89312 Günzburg, Germany. Tel.: +49 8221 96 2204; fax: +49 8221 96 2737.
    • ,
  • M. Riedel

      Affiliations

    • Department of Psychiatry, Ludwig-Maximilians-University, Nussbaumstr. 7, D-80336 Munich, Germany
    • ,
  • M. Obermeier

      Affiliations

    • Department of Psychiatry, Ludwig-Maximilians-University, Nussbaumstr. 7, D-80336 Munich, Germany
    • ,
  • R. Schennach-Wolff

      Affiliations

    • Department of Psychiatry, Ludwig-Maximilians-University, Nussbaumstr. 7, D-80336 Munich, Germany
    • ,
  • F. Seemüller

      Affiliations

    • Department of Psychiatry, Ludwig-Maximilians-University, Nussbaumstr. 7, D-80336 Munich, Germany
    • ,
  • T. Messer

      Affiliations

    • Psychiatric Clinic, District Hospital Augsburg, Dr. Mack-Str. 1, D-86156 Augsburg, Germany
    • ,
  • G. Laux

      Affiliations

    • Psychiatric Clinic, Inn-Salzach Hospital, Gabersee 7, 83512 Wasserburg/Inn, Germany
    • ,
  • H. Pfeiffer

      Affiliations

    • Psychiatric Clinic, Isar-Amper Hospital, Munich-East, Vockestr. 73, D-85540 Haar, Germany
    • ,
  • D. Naber

      Affiliations

    • Department of Psychiatry, University of Hamburg, Martinistr. 52, D-20246 Hamburg, Germany
    • ,
  • L.G. Schmidt

      Affiliations

    • Department of Psychiatry, Johannes-Gutenberg University of Mainz, Untere Zahlbacher Str. 8, 55131 Mainz, Germany
    • ,
  • W. Gaebel

      Affiliations

    • Department of Psychiatry, Heinrich-Heine-University Düsseldorf, Bergische Landstr. 2, D-40629 Düsseldorf, Germany
    • ,
  • J. Klosterkötter

      Affiliations

    • Department of Psychiatry, University of Cologne, Kerpener Str. 62, D-50924 Cologne, Germany
    • ,
  • I. Heuser

      Affiliations

    • Department of Psychiatry, Charité Berlin, Campus Benjamin Franklin, Chariteplatz 1, D-10117 Berlin, Germany
    • ,
  • K.-U Kühn

      Affiliations

    • Department of Psychiatry, University of Bonn, Sigmund-Freud-Str. 27, D-53105 Bonn, Germany
    • ,
  • M.R. Lemke

      Affiliations

    • Psychiatric Clinic, Alsterdorf Hospital, Alsterdorfer Markt, D-22297 Hamburg, Germany
    • ,
  • E. Rüther

      Affiliations

    • Department of Psychiatry, University of Göttingen, von Siebold Str. 5, D-37075 Göttingen, Germany
    • ,
  • S. Klingberg

      Affiliations

    • Department of Psychiatry, University of Tübingen, Osianderstr. 24, D-72076 Tübingen, Germany
    • ,
  • M. Gastpar

      Affiliations

    • Department of Psychiatry, University of Essen, Virchowstr. 174, D-45147 Essen, Germany
    • ,
  • R. Bottlender

      Affiliations

    • Department of Psychiatry, Ludwig-Maximilians-University, Nussbaumstr. 7, D-80336 Munich, Germany
    • ,
  • H.-J. Möller

      Affiliations

    • Department of Psychiatry, Ludwig-Maximilians-University, Nussbaumstr. 7, D-80336 Munich, Germany

Received 19 November 2009 ,Revised 29 January 2010 ,Accepted 2 February 2010.

References 

  1. Agid O, Kapur S, Arenovich T, Zipursky RB. Delayed-onset hypothesis of antipsychotic action. A hypothesis tested and rejected. Arch. Gen. Psychiatry. 2003;60:1228–1234
  2. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th Edition (DSM-IV). Washington DC: American Psychiatric Association; 1994;
  3. Andreasen NC, Carpenter WT, Kane JM, Lasser RA, Marder SR, Weinberger DR. Remission in schizophrenia: proposed criteria and rationale for consensus. Am. J. Psychiatry. 2005;162:441–449
  4. Beitinger R, Lin J, Kissling W, Leucht S. Comparative remission rates of schizophrenic patients using various remission criteria. Prog. Neuropsychopharmacol. Biol. Psychiatry. 2008;32:1643–1651
  5. Cesková E, Prikryl R, Kaspárek T, Ondrusová M. Psychopathology and treatment responsiveness of patients with first episode schizophrenia. Neurpsychiatr. Dis. Treat. 2005;1:179–185
  6. Emsley R, Rabinowitz J, Medori R. Time course for antipsychotic treatment response in first-episode schizophrenia. Am. J. Psychiatry. 2006;163:743–745
  7. Falkai P, Wobrock T, Lieberman J, Glenthoj B, Gattaz WF, Möller HJ WFSBP Task Force on Treatment Guidelines for Schizophrenia. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, Part 1: acute treatment of schizophrenia. World. J. Bio.l Psychiatry. 2005;6:132–191
  8. First MB, Spitzer RL, Gibbon M, Williams JB. Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-I) Clinical Version. Washington DC: American Psychiatric Association; 1997;
  9. Hamilton M. A rating scale for depression. J. Neurol. Neurosurg. Psychiatry. 1960;23:56–62
  10. Heerdink ER, Stolker JJ, Meijer WE, Hugenholtz GW, Egberts AC. Need for medicine-based evidence in pharmacotherapy. Br. J. Psychiatry. 2004;184:452
  11. Helldin L, Kane JM, Karilampi U, Norlander T, Archer T. Remission in prognosis of functional outcome: a new dimension in the treatment of patients with psychotic disorders. Schizophr. Res. 2007;93:160–168
  12. Jäger M, Riedel M, Messer T, Laux G, Pfeiffer H, Naber D, et al. Psychopathological characteristics and treatment response of first episode compared with multiple episode schizophrenic disorders. Eur. Arch. Psychiatry Clin. Neurosci. 2007;257:47–53
  13. Kapur S, Arenovich T, Agid O, Zipursky R, Lindborg S, Jones B. Evidence of onset of antipsychotic effects within the first 24 hours of treatment. Am. J. Psychiatry. 2005;162:939–946
  14. Kay SR. Positive and negative syndromes in schizophrenia: assessment and research. New York: Clinical and experimental psychiatry monography No. 5 Brunner/Mazel; 1991;
  15. Lasser RA, Bossie CA, Gharabawi GM, Kane JM. Remission in schizophrenia: results from a 1-year study of long-acting risperidone injection. Schizophr. Res. 2005;77:215–227
  16. Leucht S, Busch R, Hamann J, Kissling W, Kane JM. Early-onset hypothesis of antipsychotic drug action: a hypothesis tested confirmed and extended. Biol. Psychiatry. 2005;57:1543–1549
  17. Leucht S, Davis JM, Engel RR, Kane JM, Wagenpfeil S. Defining “response” in antipsychotic drug trials: recommendations for the use of scale-derived cutoffs. Neuropsychopharmacology. 2007;32:1903–1910
  18. Li M, Fletcher PJ, Kapur S. Time course of the antipsychotic effect and the underlying behavioural mechanisms. Neuropsychopharmacology. 2007;32:263–272
  19. Möller HJ. Do effectiveness (“real world”) studies on antipsychotics tell us the real truth?. Eur. Arch. Psychiatry Clin. Neurosci. 2008;258:257–270
  20. Obermeier M, Mayr A, Schennach-Wolff R, Seemüller F, Möller HJ, Riedel M. Should the PANSS be rescaled?. Schizophr. Bull. 2009;
  21. R Development Core Team. R: a language and environment for statistical computing. In: R Foundation for Statistical Computing, Vienna, Austria. 2008;http://www.R-project.org
  22. Seeman P, Lee T. Antipsychotic drugs: direct correlation between clinical potency and presynaptic action on dopamine neurons. Science. 1975;188:1217–1219
  23. Tollefson DG, Birkett MA, Kiesler GM, Wood AJ Lilly Resistant Schizophrenia Study Group. Double-blind comparison of olanzapine versus clozapine in schizophrenic patients clinically eligible for treatment with clozapine. Biol. Psychiatry. 2001;49:52–63
  24. Van Os J, Drukker M, á Campo J, Meijer J, Bak M, Delespaul P. Validation of remission criteria for schizophrenia. Am. J. Psychiatry. 2006;163:2000–2002
  25. Weinmann S, Hoerger S, Erath M, Kilian R, Gaebel W, Becker T. Implementation of a schizophrenia practice guideline. Clinical results. J. Clin. Psychiatry. 2008;69:1299–1306
  26. Wittchen HU, Wunderlich U, Gruschwitz S, Zaudig M. Strukturiertes klinisches Interview für DSM-IV (SKID). Göttingen: Hogrefe; 1997;
  27. Wölwer W, Buchkremer G, Häfner H, Klosterkötter J, Maier W, Möller HJ, et al. German research network on schizophrenia. Bridging the gap between research and care. Eur. Arch. Clin. Neurosci. 2003;253:321–329
  28. Wunderink L, Nienhuis FJ, Sytema S, Wiersma D. Predictive validity of proposed remission criteria in first-episode schizophrenic patients responding to antipsychotics. Schizophr. Bull. 2007;33:792–796
  29. Zimmermann J, Wolter A, Hannöver W, Krischke N. Frequency of remission in schizophrenia patients at one year follow-up. Psychiatr. Prax. 2009;36:182–188

PII: S0920-9964(10)00087-3

doi: 10.1016/j.schres.2010.02.002

Schizophrenia Research
Volume 118, Issue 1 , Pages 183-188 , May 2010

Article Tools

* Image Usage & Resolution